… Partilla , Kurt R. Lehner … MH Baumann, MA Ayestas Jr, JS Partilla, JR Sink, AT Shulgin,
PF Daley, SD … Baumann, MH, Partilla, JS, Lehner, KR, Thorndike, EB, Hoffman, AF, Holy, M., …

Background Treatment of stimulant-use disorders remains a formidable challenge, and the
dopamine transporter (DAT) remains a potential target for antagonist or agonist-like …

A large body of evidence supports the hypothesis that mesolimbic dopamine (DA) mediates,
in animal models, the reinforcing effects of central nervous system stimulants such as …

… , to ensure continued support, we are displaying the site without styles and JavaScript. …
John S Partilla … Michael H Baumann, Mario A Ayestas Jr, John S Partilla, Jacqueline R Sink & …

… ensure continued support, we are displaying the site without styles and JavaScript. …
John S Partilla … Zolkowska D, Jain R, Rothman RB, Partilla JS, Roth BL, Setola V et al (2009). …

3, 4-Methylenedioxymethamphetamine (MDMA, or ‘Ecstasy’) is an illicit drug that stimulates
the release of serotonin (5-HT) and dopamine (DA) from neurons. Recent evidence reveals …

There has been a dramatic rise in the abuse of synthetic cathinones known as “bath salts,”
including 3,4-methylenedioxypyrovalerone (MDPV), an analog linked to many adverse events…

Modafinil is prescribed for numerous medical conditions, but the drug's mechanism of action
is unclear. Here, we examined the interaction of modafinil with receptors and transporters in …

Ephedrine is a long-studied stimulant available both as a prescription and over-the-counter
medication, as well as an ingredient in widely marketed herbal preparations, and is also …

Amphetamine-type agents interact with the vesicular monoamine transporter type 2 (VMAT
2 ), promoting the release of intravesicular neurotransmitter and an increase in cytoplasmic …